Targeted Therapeutics
For people who suffer from gastrointestinal diseases, delivering therapeutics directly to the site of disease could enable safer and more effective drug therapies.
Encapsulating Innovation
Our mission is to reimagine therapeutics and their delivery.
We’re innovating smart capsule technology to deliver the right dose to the right place, safely.
Systemic Therapeutics
We are developing ingestible technologies to enable needle-free, systemic delivery of large molecules to the gastrointestinal tract.
Press Releases
Twitter Feed
;
We'll be at #PDAups in October presenting data on the autonomous triggering and injection efficiency of our systemic therapeutics platform for #oraldelivery of #biologics. Learn more: https://investors.bioratherapeutics.com/news-releases/news-release-details/biora-therapeutics-announces-presentation-2022-parenteral-drug
Dr. Severine Vermeire's presentation at #DDW2022 shared patient data establishing the correlation between drug levels in the colon and patient outcomes in #UC. It's why we are working on getting more drug to the site of disease for #IBD. https://www.bioratherapeutics.com/publications/tofacitinib-tissue-exposure-correlates-endoscopic-outcome
Why is this poster from #DDW2022 important? It suggests multiple inflammatory pathways for #UC, supporting the hypothesis that combination therapy could improve overall patient outcomes. https://www.bioratherapeutics.com/publications/pharmacokinetic-anti-tnf-induction-il6-inflammation-ulcerative-colitis
Connect with us